Goldman Sachs Group Inc Abcam PLC Transaction History

Goldman Sachs Group Inc

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 May 14, 2024	BUY	$21.54 - $24.41 $52.2 Million - $59.2 Million	2,423,245 New	2,423,245 $54.8 Million
Q3 2023 Nov 14, 2023	BUY	$21.54 - $24.41 $39.5 Million - $44.7 Million	1,832,947 Added 310.51%	2,423,245 $54.8 Million
Q2 2023 May 14, 2024	BUY	$12.62 - $24.47 $2.52 Million - $4.89 Million	199,736 Added 51.14%	590,298 $14.4 Million
Q2 2023 Aug 14, 2023	BUY	$12.62 - $24.47 $2.52 Million - $4.89 Million	199,736 Added 51.14%	590,298 $14.4 Million
Q1 2023 May 14, 2024	SELL	$12.98 - $17.1 $1.4 Million - $1.85 Million	-108,143 Reduced 21.68%	390,562 $5.26 Million
Q1 2023 May 11, 2023	SELL	$12.98 - $17.1 $1.4 Million - $1.85 Million	-108,143 Reduced 21.68%	390,562 $5.26 Million
Q4 2022 May 14, 2024	BUY	$13.92 - $17.0 $6.75 Million - $8.24 Million	484,794 Added 3484.97%	498,705 $7.76 Million
Q4 2022 Feb 13, 2023	BUY	$13.92 - $17.0 $6.75 Million - $8.24 Million	484,794 Added 3484.97%	498,705 $7.76 Million
Q3 2022 May 14, 2024	BUY	$13.36 - $16.75 $185,850 - $233,009	13,911 New	13,911 $209,000
Q3 2022 Nov 10, 2022	BUY	$13.36 - $16.75 $185,850 - $233,009	13,911 New	13,911 $208,000
Q2 2022 Aug 15, 2022	SELL	$12.69 - $19.25 $140,935 - $213,790	-11,106 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$15.5 - $23.89 $172,143 - $265,322	11,106 New	11,106 $203,000
Q4 2021 Feb 14, 2022	SELL	$20.04 - $23.84 $225,570 - $268,343	-11,256 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$17.38 - $21.54 $195,629 - $242,454	11,256 New	11,256 $228,000

1.03M

Ticker ABCM
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 229,044,992
Description
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.